The Bad Math That Hurts Patient Access

Patients Rising Podcast

It’s clear that we need to fix the way we measure the value of new medicines. Current methods fail to account for the benefits to caregivers, the long-term savings from keeping a job or avoiding the hospital, and the countless scientific discoveries that a new drug can lead to.

But there is a solution according to this week’s guest, biotech investor Peter Kolchinsky. He talks about his new study that looks at innovative ways to assess the real value of medicine. Peter explains how insurers use cost-effective math to determine what drugs they will and won’t cover, and alternative methods that take into account patient and caregiver needs.

Plus, Terry and Bob discuss some must-pass healthcare bills for the chronic disease community.

New Report: Getting the math right when measuring the value of new medicines

Protect Medicare patients’ right to get care at home | The Hill

Patients Rising Now Issues Must Pass for Patients List for Congress

Need help?

The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands? Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at the Patients Rising Helpline.

Have a question or comment about the show, or want to suggest a show topic or share your story as a patient correspondent?

Drop us a line: [e-mail]

The views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising, nor do the views and opinions stated on this show reflect the opinions of a guest’s current or previous employers.